Case Study
Obesity program provides cost-effective specialty care and manages GLP-1 trends
Almost half of people with excess weight turn to GLP-1s as a
first-line treatment, leading to less sustainable outcomes and rising
healthcare costs. By partnering with Vida, we are improving access to obesity specialty care—including medical nutrition therapy (MNT) and
anti-obesity medications (AOMs)— helping organizations manage costs
and deliver better results.
Download our newest case study with to learn how you can lower costs and provide better wraparound solutions for your people with Vida.
